ArticleRheumatology and therapy2023

Risk of Macrophage Activation Syndrome in Patients with Adult-Onset Still's Disease Treated with IL-1 and IL-6 Inhibitors: A Meta-analysis and Single-Center Experience.

Soichiro Adachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.